ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reaffirmed by equities research analysts at Peel Hunt in a report released on Thursday, ThisIsMoney.Co.Uk reports.
A number of other analysts have also commented on the stock. Goldman Sachs Group lifted their target price on shares of ConvaTec Group from GBX 118 ($1.55) to GBX 183 ($2.41) and gave the stock a “neutral” rating in a report on Wednesday, October 30th. Shore Capital lowered shares of ConvaTec Group to a “hold” rating in a report on Thursday, January 23rd. Peel Hunt reaffirmed a “buy” rating and set a GBX 280 ($3.68) target price on shares of ConvaTec Group in a report on Friday, October 25th. Credit Suisse Group lowered shares of ConvaTec Group to an “underperform” rating in a report on Thursday, October 17th. Finally, Barclays reaffirmed an “equal weight” rating on shares of ConvaTec Group in a report on Monday, February 3rd. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company’s stock. ConvaTec Group currently has an average rating of “Hold” and an average price target of GBX 202.64 ($2.67).
CTEC opened at GBX 216 ($2.84) on Thursday. The company has a fifty day moving average price of GBX 207.04 and a two-hundred day moving average price of GBX 188.91. The company has a debt-to-equity ratio of 104.76, a quick ratio of 1.58 and a current ratio of 2.37. ConvaTec Group has a 52 week low of GBX 113.25 ($1.49) and a 52 week high of GBX 225.80 ($2.97). The firm has a market capitalization of $4.28 billion and a PE ratio of 27.00.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Recommended Story: What member countries make up the G-20?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.